thiophenes has been researched along with Chronic Disease in 94 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (12.77) | 18.7374 |
| 1990's | 11 (11.70) | 18.2507 |
| 2000's | 32 (34.04) | 29.6817 |
| 2010's | 35 (37.23) | 24.3611 |
| 2020's | 4 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Markham, A | 1 |
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Flamm, SL; Nilles, KM | 1 |
| Lozano, ML | 1 |
| Chen, M; Chen, X; Guo, L; Wang, F; Wu, B; Xu, H; Xu, Y; Yu, F; Yu, J; Zhang, T; Zhou, C | 1 |
| Dhananjayan, K; Gunawardena, D; Gyengesi, E; Liang, H; Millington, C; Münch, G; Niedermayer, G; Sirijovski, D; Sonego, S; Venigalla, M | 1 |
| Shirley, M | 1 |
| Carmichael, SL; Forde, EE; Frelinger, AL; Michelson, AD; Smolensky Koganov, E | 1 |
| Al-Samkari, H | 1 |
| Batur, S; Dobrucali, A; Sadri, S; Sisman, G | 1 |
| Pitchot, W | 1 |
| Aung, TH; Foo, D; Francis, PJ; Ho, HH; Huang, W; Ong, PJ; Wong, CP; Yeo, D | 1 |
| Boos, CJ; Camm, AJ; Nam, M | 1 |
| Hoza, J; Kellnerova, R; Salzman, R; Schalek, P; Starek, I | 1 |
| Aledort, LM; Bussel, JB; Cuker, A; Kessler, CM; Kuter, DJ; McIntosh, J; Pendergrass, KB; Tang, S | 1 |
| de Knegt, RJ; Maan, R; Veldt, BJ | 1 |
| Lee, BH; Lee, JH; Lim, CJ; Oh, KS; Park, BK; Seo, HW; Yi, KY | 1 |
| Forde, G; Stanos, S | 1 |
| Voznesenskaia, TG | 1 |
| Nurden, AT; Nurden, P; Viallard, JF | 1 |
| Ememlin, AIu; Kashin, AV; Odinak, MM | 1 |
| Backonja, M; Chappell, A; Detke, M; Iyengar, S; Liu-Seifert, H; Ossanna, M; Skljarevski, V; Zhang, Q | 1 |
| Aquino, M; Bruno, I; Guerrero, MD; Payá, M; Riccio, R; Terencio, MC | 1 |
| Begley, A; Dew, MA; Karp, JF; Miller, MD; Reynolds, CF; Weiner, DK | 1 |
| Hughes, RA; Lunn, MP; Wiffen, PJ | 1 |
| Apazoglou, K; Farley, S; Giros, B; Tzavara, ET; Witkin, JM | 1 |
| Gaine, SP; Murphy, DM; O'Callaghan, DS | 1 |
| Bitter, I; Karamustafalioglu, O; Koponen, H; Mohr, P; Sartorius, N; Seifritz, E; Svestka, J | 1 |
| Abramowicz, D; Faoro, V; Huez, S; Lamotte, M; Naeije, R; Neupane, S; Retailleau, K | 1 |
| Mazza, M; Mazza, O; Mazza, S; Padua, L; Pazzaglia, C | 1 |
| Atkinson, JH; Backonja, M; Chappell, AS; Desaiah, D; Detke, MJ; Iyengar, S; Liu-Seifert, H; Skljarevski, V; Zhang, Q | 1 |
| Acharya, N; Crucitti, A; Hall, JA; Oakes, TM; Utterback, BG; Wang, F | 1 |
| Alaka, KJ; Desaiah, D; Miazgowski, T; Palacios, S; Patrick, K; Skljarevski, V; Zhang, S | 1 |
| Backonja, M; Chappell, AS; Murray, I; Skljarevski, V; Walker, DJ; Zhang, S | 1 |
| Burton, P; Gheorghiade, M; Greenberg, BH; Mehra, M; Nadar, VK; Plotnikov, AN; Sun, X; Thyssen, A; Tian, H; Zolynas, R | 1 |
| Duenas, H; Gaynor, P; McCarberg, B; Shoemaker, S; Zheng, W | 1 |
| Marcus, DA | 1 |
| Bauleo, C; Catapano, G; Formichi, B; Genovesi, D; Giuntini, C; Mannucci, F; Marini, C; Michelassi, C; Monti, S; Prediletto, R | 1 |
| Liu, X; Mullins, CD; Wang, J | 1 |
| Huisman, MV; Kooiman, J; van de Peppel, WR; van der Meer, FJ | 1 |
| Alexopoulos, D; Davlouros, P; Hahalis, G; Mavronasiou, E; Panagiotou, A; Plakomyti, TE; Xanthopoulou, I | 1 |
| Basra, SS; Lakkis, NM; Tsai, P | 1 |
| Batchelder, ST; Black, SR; Chen, Y; Deliyannides, DA; Hellerstein, DJ; McGrath, PJ; O'Shea, D; Stewart, JW; Withers, A | 1 |
| Elmes, SJ; McIntosh, F; Perkins, MN; Rashid, MH; Theberge, Y | 1 |
| Drabik, A; Goerge, T; Kerk, N; Luger, TA; Schneider, SW | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Fishbain, DA | 1 |
| Bibova, J; Hampl, V; Herget, J; Novotna, J; Povysilova, V; Vankova, M | 1 |
| Leech, JN; Stewart, JA; Stewart, WC | 1 |
| Ferguson, MB; Goldstein, DJ; Mallinckrodt, CH; Raskin, J | 1 |
| Delgado, PL | 1 |
| Briley, M | 1 |
| Blackburn-Munro, G; Bomholt, SF; Mikkelsen, JD | 1 |
| Abashidze, TB; Gorgoshidze, ML | 1 |
| Ishikawa, S; Nakamura, Y; Sakai, H; Sawaguchi, S; Shinjyo, S | 1 |
| Viktrup, L; Yalcin, I | 1 |
| Lowry, DR; Malinin, AI; Meilman, H; Midei, MG; Serebruany, VL | 1 |
| Desaiah, D; Perahia, DG; Pritchett, YL; Raskin, J | 1 |
| Hajak, G | 1 |
| Ouslander, JG; Zarowitz, BJ | 1 |
| Meighen, KG | 1 |
| Salmon, JF; Sharma, T | 1 |
| Wallace, JM | 1 |
| Farber, R; Landin, R; Lankford, DA; Lydiard, RB; Seiden, DJ; Walsh, JK | 1 |
| Detke, MJ; Gilaberte, I; Hudson, JI; Perahia, DG; Wang, F; Watkin, JG | 1 |
| Gremmler, B; Kisters, K; Kunert, M; Schleiting, H; Ulbricht, LJ | 1 |
| Bertini, M; Clini, EM; Coletti, O; Costi, S; Crisafulli, E; Fabbri, LM; Lorenzi, C; Lucic, S; Zanasi, E | 1 |
| Kaverina, IV; Leonova, AR; Voznesenskaia, TG | 1 |
| Fishbain, DA; Gonzales, J; Hall, J; Mallinckrodt, C; Meyers, AL | 1 |
| Cacciatore, L; De Marco, F; Giardina, MG; Matarazzo, M | 1 |
| Kamiya, K; Katsumura, T; Mishima, Y; Sakaguchi, S; Sakuma, A; Tanabe, T | 1 |
| Badimón, JJ; Borruel, MT; Escolar, G; Martínez, JC; Villaverde, CA | 1 |
| Baldini, EV; Donnetta, AM; Gorrini, M; Iadarola, P; Luisetti, M; Marchioni, CF; Moretti, M; Venturini, R | 1 |
| Hanard, T; Mancini, C; Marchioni, CF; Noseda, G; Polu, JM; Taytard, A | 1 |
| Dechant, KL; Noble, S | 1 |
| Armegioiu, M; Gafencu, O; Ionita, M | 1 |
| Adelman, AE; Fiscella, RG; Fishman, GA; Grover, S | 1 |
| Barisani, T; Baumgartner, I; Biowski, R; Hommer, A; Kaminski, S; Koyuncu, D | 1 |
| Bucci, MG; Centofanti, M; Manni, GL; Napoli, D; Parisi, V | 1 |
| D'Andrea, A; D'Andrea, D; Ferreri, G | 1 |
| Aubier, M; Berdah, L | 1 |
| Hayashi, K; Hosoe, H; Kaise, T; Ohmori, K | 1 |
| Artese, L; di Mola, FF; Di Sebastiano, P; Innocenti, P; Mascetta, G; Pernthaler, H; Rossi, C | 1 |
| Frank, A | 1 |
| Kuokkanen, K | 1 |
| Standal, JE | 1 |
| Matevosian, AA | 1 |
| Corazza, GR; D'Ambro, A; Flacco, L; Gasbarrini, G; Miglio, F; Pesa, O; Schiavone, C; Stefanini, GF | 1 |
| Casalini, A; D'Ippolito, R; Del Donno, M; Fregnan, GB; Olivieri, D | 1 |
| Casadei, MC; Fregnan, GB; Guerzoni, P; Marchioni, CF; Moretti, M; Muratori, M; Scuri, R | 1 |
| Bronchi, GF; Carini, A; Karavassili, M; Tesi, M | 1 |
| Fregnan, GB; Gazzani, G; Mazzone, A; Ricevuti, G; Uccelli, E | 1 |
| Allegra, L; Bossi, R; Braga, PC | 1 |
| Bowles, MJ; Khurmi, NS; Kohli, RS; Raftery, EB | 1 |
23 review(s) available for thiophenes and Chronic Disease
| Article | Year |
|---|---|
Avatrombopag: A Review in Thrombocytopenia.
Topics: Adult; Animals; Chronic Disease; Humans; Liver Diseases; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia | 2021 |
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Thrombocytopenia in Chronic Liver Disease: New Management Strategies.
Topics: Chronic Disease; Cinnamates; Hemorrhage; Humans; Liver Diseases; Platelet Count; Platelet Transfusion; Receptors, Thrombopoietin; Risk Factors; Surgical Procedures, Operative; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoiesis | 2020 |
Avatrombopag for the management of thrombocytopenia in patients with chronic liver disease.
Topics: Adult; Chronic Disease; Humans; Liver Diseases; Thiazoles; Thiophenes; Thrombocytopenia | 2021 |
Avatrombopag: First Global Approval.
Topics: Chronic Disease; Drug Approval; Humans; Liver Diseases; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia; United States; United States Food and Drug Administration | 2018 |
Avatrombopag maleate for the treatment of periprocedural thrombocytopenia in patients with chronic liver disease.
Topics: Animals; Chronic Disease; Drug Interactions; Hematologic Agents; Humans; Liver Diseases; Perioperative Period; Thiazoles; Thiophenes; Thrombocytopenia; Treatment Outcome | 2018 |
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Chronic Disease; Dabigatran; Drug Monitoring; Heart Failure; Hemorrhage; Humans; Morpholines; Outcome Assessment, Health Care; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Warfarin | 2014 |
Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.
Topics: Benzoates; Chronic Disease; Disease Management; Hepatitis C, Chronic; Humans; Hydrazines; Liver Diseases; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoietin | 2015 |
Practical management strategies for the chronic pain patient.
Topics: Administration, Cutaneous; Amines; Analgesics; Antidepressive Agents, Tricyclic; Carbamazepine; Chronic Disease; Clinical Protocols; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Monitoring; Drug Tolerance; Duloxetine Hydrochloride; Family Practice; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Middle Aged; Pain; Practice Guidelines as Topic; Pregabalin; Randomized Controlled Trials as Topic; Substance-Related Disorders; Thiophenes; Treatment Outcome | 2007 |
New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura.
Topics: Benzoates; Carrier Proteins; Chronic Disease; Drug Approval; Hemorrhage; Humans; Hydrazines; Megakaryocytes; Methacrylates; Patient Selection; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Safety; Thiazoles; Thiophenes; Thrombopoiesis; Thrombopoietin; Treatment Outcome; United States; United States Food and Drug Administration | 2009 |
Duloxetine for treating painful neuropathy or chronic pain.
Topics: Analgesics; Chronic Disease; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Randomized Controlled Trials as Topic; Thiophenes | 2009 |
Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Topics: Adrenergic Uptake Inhibitors; Chronic Disease; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Polypharmacy; Randomized Controlled Trials as Topic; Thiophenes | 2010 |
Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Topics: Aged; Analgesics; Arthralgia; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Knee Joint; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Pain; Thiophenes; Weight Gain; Weight Loss | 2011 |
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine; Uremia | 2011 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
Common pathways of depression and pain.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Clinical experience with dual action antidepressants in different chronic pain syndromes.
Topics: Antidepressive Agents; Chronic Disease; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Topics: Analgesics; Antidepressive Agents; Chronic Disease; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Thiophenes; Treatment Outcome | 2006 |
[Dual acting reuptake inhibitors in the treatment of depression and pain].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Chronic Disease; Depression; Diabetes Complications; Diabetes Mellitus, Type 2; Duloxetine Hydrochloride; Humans; Norepinephrine; Pain; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Treatment Outcome | 2006 |
The application of evidence-based principles of care in older persons (issue 6): urinary incontinence.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Aged; Algorithms; Chronic Disease; Cost of Illness; Decision Trees; Drug Monitoring; Duloxetine Hydrochloride; Ephedrine; Evidence-Based Medicine; Exercise Therapy; Geriatric Assessment; Geriatrics; Humans; Muscarinic Antagonists; Pelvic Floor; Practice Guidelines as Topic; Receptors, Adrenergic, alpha-1; Referral and Consultation; Research Design; Risk Factors; Thiophenes; Toilet Training; Treatment Outcome; Urinary Incontinence; Urodynamics | 2007 |
Update on pharmacotherapy guidelines for treatment of neuropathic pain.
Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Guidelines as Topic; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes | 2007 |
Erdosteine.
Topics: Animals; Bronchitis; Chronic Disease; Clinical Trials as Topic; Expectorants; Humans; Thioglycolates; Thiophenes | 1996 |
[New aspects of long-term asthma therapy].
Topics: Adrenergic beta-Agonists; Adrenocorticotropic Hormone; Allergens; Asthma; Chronic Disease; Cromolyn Sodium; Desensitization, Immunologic; Drug Therapy, Combination; Glucocorticoids; Humans; Parasympatholytics; Piperidines; Theophylline; Thiophenes | 1979 |
37 trial(s) available for thiophenes and Chronic Disease
| Article | Year |
|---|---|
Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease.
Topics: Blood Platelets; Chronic Disease; Double-Blind Method; Hematologic Agents; Humans; Liver Diseases; Platelet Activation; Platelet Count; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoiesis; Time Factors; Treatment Outcome; United States | 2018 |
Efficacy and safety of erdosteine in the treatment of chronic rhinosinusitis with nasal polyposis - a pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Drug Therapy, Combination; Expectorants; Female; Humans; Male; Middle Aged; Mometasone Furoate; Nasal Polyps; Pilot Projects; Pregnadienediols; Prospective Studies; Rhinitis; Sinusitis; Thioglycolates; Thiophenes; Treatment Outcome; Young Adult | 2013 |
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drugs, Investigational; Epistaxis; Fatigue; Female; Headache; Humans; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Time Factors; Treatment Outcome | 2014 |
[Cymbalta in the treatment of chronic pain syndromes].
Topics: Adult; Antidepressive Agents; Chronic Disease; Depression; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Middle Aged; Pain; Pain Measurement; Syndrome; Thiophenes; Treatment Outcome | 2009 |
A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.
Topics: Analysis of Variance; Chronic Disease; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Patient Selection; Quality of Life; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2009 |
Pulmonary artery pressure limits exercise capacity at high altitude.
Topics: Acute Disease; Adult; Altitude; Blood Pressure; Chronic Disease; Endothelin A Receptor Antagonists; Exercise; Female; Humans; Hypertension, Pulmonary; Hypoxia; Isoxazoles; Kidney; Male; Middle Aged; Oxygen Consumption; Pulmonary Artery; Pulmonary Gas Exchange; Thiophenes; Vascular Resistance; Young Adult | 2010 |
Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain.
Topics: Adult; Aged; Chronic Disease; Citalopram; Duloxetine Hydrochloride; Female; Health Surveys; Humans; Low Back Pain; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome | 2010 |
Efficacy and safety of duloxetine in patients with chronic low back pain.
Topics: Adult; Aged; Chronic Disease; Diarrhea; Double-Blind Method; Duloxetine Hydrochloride; Fatigue; Female; Humans; Low Back Pain; Male; Middle Aged; Nausea; Pain Measurement; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Treatment Outcome | 2010 |
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
Topics: Chronic Disease; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2010 |
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
Topics: Adult; Aged; Analgesics; Antidepressive Agents; Chronic Disease; Clinical Protocols; Disability Evaluation; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Placebos; Severity of Illness Index; Surveys and Questionnaires; Thiophenes; Treatment Outcome | 2010 |
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Biomarkers; Chronic Disease; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Heart Failure; Humans; Male; Middle Aged; Morpholines; Peptide Fragments; Peptide Hydrolases; Prothrombin; Rivaroxaban; Thiophenes; Thrombophilia | 2011 |
Prasugrel overcomes high on-clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150 mg) clopidogrel.
Topics: Aged; Chronic Disease; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Female; Humans; Male; Middle Aged; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Single-Blind Method; Thiophenes; Ticlopidine; Treatment Outcome | 2011 |
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Topics: Adult; Aged; Antidepressive Agents; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Personality Inventory; Prospective Studies; Psychometrics; Social Adjustment; Temperament; Thiophenes; Young Adult | 2012 |
Acute and chronic ocular symptoms of dorzolamide 2% compared with placebo.
Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Chronic Disease; Double-Blind Method; Eye Diseases; Female; Humans; Male; Ophthalmic Solutions; Pain; Pain Measurement; Sulfonamides; Thiophenes; Time Factors | 2003 |
Duloxetine in the long-term treatment of major depressive disorder.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antidepressive Agents; Chronic Disease; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Long-Term Care; Male; Middle Aged; Personality Inventory; Thiophenes; Treatment Outcome | 2003 |
[Effect of a combination of teveten and prestarium in patients with chronic heart failure].
Topics: Acrylates; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Imidazoles; Male; Perindopril; Thiophenes | 2005 |
Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.
Topics: Aged; Antihypertensive Agents; Chronic Disease; Drug Combinations; Female; Glaucoma, Angle-Closure; Humans; Instillation, Drug; Intraocular Pressure; Japan; Latanoprost; Male; Ophthalmic Solutions; Patient Compliance; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2005 |
Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Topics: Aged; Benzodiazepines; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Tolerance; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Sleep Initiation and Maintenance Disorders; Thiophenes | 2006 |
Duloxetine in the treatment of major depressive disorder: an open-label study.
Topics: Chronic Disease; Depressive Disorder, Major; Disability Evaluation; Duloxetine Hydrochloride; Humans; Quality of Life; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Thiophenes; Treatment Outcome | 2007 |
Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors.
Topics: Acrylates; Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Blood Pressure; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Vascular Resistance | 2007 |
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Topics: Administration, Oral; Aged; Bronchiectasis; Chronic Disease; Combined Modality Therapy; Expectorants; Female; Forced Expiratory Volume; Humans; Male; Mucus; Physical Therapy Modalities; Pilot Projects; Prospective Studies; Respiratory System; Thioglycolates; Thiophenes | 2007 |
Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Elbow; Female; Foot; Humans; Ischemia; Knee; Male; Middle Aged; Pain; Placebos; Platelet Aggregation; Skin Ulcer; Thiophenes; Thromboangiitis Obliterans; Ticlopidine | 1982 |
Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Topics: Aged; Amoxicillin; Bronchitis; Chronic Disease; Double-Blind Method; Expectorants; Female; Humans; Male; Middle Aged; Penicillins; Prospective Studies; Thioglycolates; Thiophenes | 1995 |
Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Carbonic Anhydrase Inhibitors; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Retinitis Pigmentosa; Sulfonamides; Thiophenes; Visual Acuity | 1997 |
Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Sulfonamides; Thiophenes; Treatment Outcome | 1997 |
Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Miotics; Pilocarpine; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 1998 |
[Multicenter, controlled, double-blind study of the efficacy and tolerance of Vectrine (erdostein) versus placebo in the treatment of stabilized chronic bronchitis with hypersecretion].
Topics: Administration, Oral; Adult; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Dyspnea; Expectorants; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thioglycolates; Thiophenes; Treatment Outcome | 1999 |
A new antihistamine hc20-511 compared with dimetinden (fenistil retard) in the treatment of chronic urticaria and other pruritic dermatoses.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Dimethindene; Drug Therapy, Combination; Female; Fumarates; Histamine H1 Antagonists; Humans; Male; Middle Aged; Piperidines; Pruritus; Skin Diseases; Thiophenes; Urticaria; Vomiting | 1975 |
Pizotifen as an antidepressant.
Topics: Acute Disease; Adjustment Disorders; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Humans; Male; Pizotyline; Psychotic Disorders; Thiophenes | 1977 |
[Comparative evaluation of the new antiserotonin preparations, sandomigran and lizenil, in treating patients suffering from migraine].
Topics: Adult; Cerebrovascular Circulation; Chronic Disease; Clinical Trials as Topic; Czechoslovakia; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Migraine Disorders; Pizotyline; Serotonin Antagonists; Sweden; Thiophenes; Urea | 1976 |
[Use of citiolone in chronic hepatitides. Results of a research with clinical and laboratory controls].
Topics: Adolescent; Adult; Aged; Chronic Disease; Drug Evaluation; Female; Hepatitis; Hepatitis, Viral, Human; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Research; Thiophenes; Transaminases | 1977 |
Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis.
Topics: Aged; Bronchitis; Bronchoscopy; Chronic Disease; Double-Blind Method; Expectorants; Female; Fenoterol; Humans; Male; Middle Aged; Mucociliary Clearance; Mucus; Placebos; Smoking; Thioglycolates; Thiophenes | 1991 |
Effects of erdosteine on sputum biochemical and rheologic properties: pharmacokinetics in chronic obstructive lung disease.
Topics: Bronchitis; Chronic Disease; Double-Blind Method; Expectorants; Humans; Male; Rheology; Sputum; Theophylline; Thioglycolates; Thiophenes | 1990 |
Therapy of atherosclerotic arteriopathy of lower limbs. Aspects and results.
Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Clinical Trials as Topic; Glycosaminoglycans; Heparin; Humans; Injections, Subcutaneous; Leg; Pentoxifylline; Streptokinase; Thiophenes; Ticlopidine; Urokinase-Type Plasminogen Activator; Vasodilator Agents | 1985 |
Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
Topics: Aged; Amoxicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Expectorants; Female; Humans; Male; Middle Aged; Sputum; Thioglycolates; Thiophenes | 1988 |
Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
Topics: Adult; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Elasticity; Expectorants; Glycine; Humans; Middle Aged; Random Allocation; Rheology; Sputum; Sulfides; Thiophenes; Viscosity | 1987 |
Does placebo improve indexes of effort-induced myocardial ischemia? An objective study in 150 patients with chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Placebos; Thiophenes; Ticlopidine | 1986 |
34 other study(ies) available for thiophenes and Chronic Disease
| Article | Year |
|---|---|
Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models.
Topics: Acute Disease; Animals; Basic-Leucine Zipper Transcription Factors; Chronic Disease; Disease Models, Animal; Epilepsy, Temporal Lobe; GABA Plasma Membrane Transport Proteins; GABAergic Neurons; gamma-Aminobutyric Acid; Gene Expression Regulation; Hippocampus; Humans; Inhibitory Postsynaptic Potentials; Isoquinolines; Kindling, Neurologic; Mice, Inbred C57BL; Mice, Knockout; Nuclear Receptor Subfamily 1, Group D, Member 1; RNA, Messenger; Seizures; Small Molecule Libraries; Thiophenes | 2021 |
Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cerebellum; Chronic Disease; Hippocampus; Humans; Inflammation; Interleukin-6; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Piperazines; Pyruvaldehyde; Thiophenes; Tissue Distribution; Tumor Necrosis Factor-alpha | 2018 |
Collagenous colitis and ileitis under treatment with duloxetine.
Topics: Aged; Antidepressive Agents; Biopsy; Chronic Disease; Colitis, Collagenous; Colon; Colonoscopy; Depressive Disorder, Major; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Ileitis; Ileum; Recurrence; Thiophenes; Treatment Outcome; Withholding Treatment | 2012 |
[Is there a place for the physician's hopelesness in the treatment of depression?].
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Physician's Role; Piperazines; Quinolones; Remission Induction; Risk Factors; Thiophenes; Treatment Outcome | 2013 |
Successful treatment of a patient with chronic thromboembolic pulmonary hypertension with rivaroxaban.
Topics: Adult; Anticoagulants; Chronic Disease; Female; Humans; Hypertension, Pulmonary; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome | 2013 |
A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.
Topics: Animals; Body Weight; Cardiomegaly; Cell Line; Chronic Disease; Electrocardiography; Heart; Heart Failure; Hemodynamics; Humans; Male; Mice; Myocardium; Organ Size; Piperidines; Pressure; Rats; Receptors, G-Protein-Coupled; Substrate Specificity; Thiophenes | 2017 |
[Chronic pain and depression].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Chronic Disease; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Pain; Prevalence; Thiophenes | 2008 |
Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression.
Topics: 4-Butyrolactone; Acetates; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Behavior, Animal; Blood Platelets; Cattle; Chronic Disease; Gene Expression Regulation, Enzymologic; Humans; Hyperalgesia; Inflammation; Intramolecular Oxidoreductases; Leukotriene B4; Male; Mice; Neutrophils; Prostaglandin-E Synthases; Thiophenes; Thromboxane B2 | 2009 |
Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study.
Topics: Aged; Anxiety; Chronic Disease; Comorbidity; Depressive Disorder, Major; Disability Evaluation; Disease Management; Duloxetine Hydrochloride; Female; Health Status; Humans; Low Back Pain; Male; Pain Measurement; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Efficacy; Sleep; Surveys and Questionnaires; Thiophenes | 2010 |
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodiazepines; Chronic Disease; Depression; Depressive Disorder; Disease Models, Animal; Emotions; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred BALB C; Motor Activity; Receptors, AMPA; Stress, Psychological; Sulfonamides; Thiophenes | 2010 |
Relief of chronic neuropathic pain through endothelin antagonism.
Topics: Chronic Disease; Endothelin A Receptor Antagonists; Humans; Isoxazoles; Male; Middle Aged; Pain Measurement; Sciatic Neuropathy; Thiophenes | 2010 |
Management of depression in the presence of pain symptoms.
Topics: Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Mind-Body Relations, Metaphysical; Norepinephrine; Pain; Psychotherapy; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Duloxetine use in painful conditions.
Topics: Analgesia; Analgesics; Animals; Antidepressive Agents; Chronic Disease; Disease Models, Animal; Duloxetine Hydrochloride; Humans; Low Back Pain; Osteoarthritis; Pain; Retrospective Studies; Thiophenes; Treatment Outcome | 2011 |
Improved survival in patients with inoperable chronic thromboembolic pulmonary hypertension.
Topics: Acid-Base Equilibrium; Aged; Antihypertensive Agents; Blood Gas Analysis; Bosentan; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Exercise Test; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Oxygen Consumption; Oxygen Inhalation Therapy; Piperazines; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Sulfones; Survival Rate; Thiophenes; Thromboembolism; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2013 |
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
Topics: Adolescent; Adult; Algorithms; Antidepressive Agents; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dosage Forms; Duloxetine Hydrochloride; Female; Humans; Male; Medication Adherence; Middle Aged; Pain; Retrospective Studies; Somatoform Disorders; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2011 |
Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.
Topics: Administration, Oral; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biomarkers; Chronic Disease; Creatinine; Dabigatran; Fibrinolytic Agents; Glomerular Filtration Rate; Humans; Incidence; Kidney; Kidney Diseases; Morpholines; Netherlands; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Severity of Illness Index; Thiophenes | 2011 |
Pharmacological validation of early and late phase of rat mono-iodoacetate model using the Tekscan system.
Topics: Alkylating Agents; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Chronic Disease; Dexamethasone; Dinoprostone; Disease Models, Animal; Duloxetine Hydrochloride; Hindlimb; Iodoacetates; Male; Morphine; Muscle Fibers, Skeletal; Naproxen; Neurons, Afferent; Pain Measurement; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Restraint, Physical; Synovial Fluid; Thiophenes; Weight-Bearing | 2013 |
Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy.
Topics: Adolescent; Anticoagulants; Capillaries; Chronic Disease; Factor Xa Inhibitors; Female; Humans; Infarction; Livedo Reticularis; Morpholines; Rivaroxaban; Skin; Thiophenes; Young Adult | 2013 |
Analgesic effects of antidepressants.
Topics: Analgesics; Antidepressive Agents; Chronic Disease; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; Humans; Pain; Review Literature as Topic; Thiophenes | 2003 |
Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats.
Topics: Animals; Chronic Disease; Collagen; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Metalloendopeptidases; Phenylalanine; Protease Inhibitors; Pulmonary Circulation; Rats; Rats, Wistar; Specific Pathogen-Free Organisms; Thiophenes | 2003 |
Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.
Topics: Acute Disease; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Chronic Disease; Citalopram; Disease Models, Animal; Duloxetine Hydrochloride; Male; Mianserin; Mirtazapine; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Thiophenes | 2005 |
Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Comorbidity; Controlled Clinical Trials as Topic; Demography; Depression; Diabetes Mellitus; Duloxetine Hydrochloride; Estrogens; Female; Humans; Lung Diseases; Middle Aged; Obesity; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2007 |
Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.
Topics: Angina Pectoris; Aspirin; Chronic Disease; Coronary Stenosis; Drug Therapy, Combination; Humans; Male; Middle Aged; Myocardial Ischemia; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Thiophenes; Treatment Refusal | 2006 |
Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.
Topics: Abdominal Pain; Adolescent; Antidepressive Agents; Chronic Disease; Comorbidity; Crohn Disease; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Pain; Sick Role; Thiophenes | 2007 |
Hypotony and choroidal detachment as a complication of topical combined timolol and dorzolamide.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Cataract Extraction; Choroid Diseases; Chronic Disease; Drug Interactions; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypotension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Recurrence; Sulfonamides; Thiophenes; Timolol; Trabeculectomy | 2007 |
[Treatment of chronic back pain with antidepressant cymbalta: an experimental study].
Topics: Adult; Antidepressive Agents; Chronic Disease; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Retrospective Studies; Severity of Illness Index; Thiophenes | 2007 |
Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Topics: Antidepressive Agents; Chronic Disease; Comorbidity; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Incidence; Male; Middle Aged; Pain; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Thiophenes; Treatment Outcome; United States | 2008 |
Ticlopidine can cause chronic diarrhoea.
Topics: Aged; Anticoagulants; Chronic Disease; Diarrhea; Humans; Male; Thiophenes; Ticlopidine | 1984 |
[Synergistic action of sodium thiophencarboxylate and bromhexine in chronic bronchitis in rats].
Topics: Animals; Bromhexine; Bronchitis; Carboxylic Acids; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Expectorants; Rats; Rats, Inbred Strains; Thiophenes | 1981 |
Effects of MR889, a cyclic thiolic neutrophil elastase inhibitor, on rheologic properties of mucus.
Topics: alpha 1-Antitrypsin; Animals; Bronchitis; Chronic Disease; Elasticity; Gastric Mucosa; Humans; In Vitro Techniques; Leukocyte Elastase; Mucus; Pancreatic Elastase; Sputum; Swine; Thiophenes; Viscosity | 1994 |
[Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Chronic Disease; Combined Modality Therapy; Corneal Edema; Drug Evaluation; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Sulfonamides; Thiophenes; Time Factors | 1997 |
Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility.
Topics: Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; Cell Count; Chronic Disease; Cornea; Drug Therapy, Combination; Endothelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Sensation; Sulfonamides; Thiophenes; Timolol | 1998 |
Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice.
Topics: Administration, Oral; Animals; Bronchitis; Bronchoalveolar Lavage Fluid; Chronic Disease; Disease Models, Animal; Expectorants; Hypochlorous Acid; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Reactive Oxygen Species; Thioglycolates; Thiophenes; Tumor Necrosis Factor-alpha | 2000 |
Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.
Topics: Animals; Chronic Disease; Colitis, Ulcerative; Disease Models, Animal; Hematoxylin; Intestinal Mucosa; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Peroxidase; Phenylalanine; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Thiophenes; Trinitrobenzenesulfonic Acid | 2001 |